googlemarker

SUN PHARMACEUTICAL INDUSTRIES LTD.

NSE : SUNPHARMABSE : 524715ISIN CODE : INE044A01036Industry : Pharmaceuticals & Drugs MCap (Rs. in Mn) : 1372404.95 Face Value (Rs.) : 1 House : Sun Pharma
BSE572.00-4.25 (-0.74 %)
PREV CLOSE (Rs.) 576.25
OPEN PRICE (Rs.) 577.10
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 572.00 (655)
VOLUME 331179
TODAY'S LOW / HIGH (Rs.)568.50 579.95
52 WK LOW / HIGH (Rs.)433.15 728.45
NSE572.10-4.6 (-0.8 %)
PREV CLOSE( Rs. ) 576.70
OPEN PRICE (Rs.) 580.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 572.10 (710)
VOLUME 4693971
TODAY'S LOW / HIGH(Rs.) 567.60 580.65
52 WK LOW / HIGH (Rs.)432.7 729.05
1D 1M 3M 1Y 3Y 5Y
Trade Value (Rs. in Lacs)
1900.77
Dividend Yield(%)
0.61
TTM EPS (Rs.)
-3.26
P/E Ratio
0.00
Book Value (Rs.)
81.15
Face Value (Rs.)
1
MCap (Rs. in Mn)
1372404.95
Price/Earning (TTM)
-383.64
Price/Sales (TTM)
18.75
Price/Book (MRQ)
7.05
PAT Margin (%)
-0.45
ROCE (%)
0.70
Incorporation Year : 01-03 1993

Management Info :

Israel Makov - Chairman Dilip S Shanghvi - Managing Director

Registered Office :

Address : Sun Pharma Advanced Research Centre (S P A R C),Tandalja,,
Vadodara,
Gujarat-390020

Phone : 0265- 5515500 / 5515600 / 5515700

Website : www.sunpharma.com

Registrars Details :

Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE, MCX
17Jan TCS, Sun Pharma and GAIL to see some a
Tata Consultancy Services (TCS) has entered into partnership with M&..
17Jan Sun Pharma settles Patent Litigation f
Sun Pharmaceutical Industries’ wholly owned subsidiaries (collectively S..
17Jan Sun Pharma gains on settling Patent Li
Sun Pharmaceutical Industries is currently trading at Rs. 581.55, up by..
QTR Sep 17 ANNUAL 17
Net Profit5770.5-349.5
Gross Profit 5736.3 -324.4
Operating Profit 8082.9 6096.8
Net Sales 18238.4 78067
Rs. in Millions
Sanofi India (BSE)
img  4728.85 (1.41%)
M.Cap (Rs. in Cr)10890.84
Coral Laboratories (BSE)
img  936.70 (4.66%)
M.Cap (Rs. in Cr)334.65
Abbott India (BSE)
img  5466.30 (0.62%)
M.Cap (Rs. in Cr)11615.51
Biocon (BSE)
img  569.85 (5.61%)
M.Cap (Rs. in Cr)34191.00
PROMOTERS
54.38%
NON-INSTITUTION
13.57%
FI/BANKS/INSURANCE
7.17%
MUTUAL FUNDS/UTI
6.55%
GOVERNMENT
0%
FII
0%
Prevent Unauthorised transactions in your account. Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day.....Issued in the interest of investors.  |  No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account. |  KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
Dear Client, Pursuant to SEBI regulation, update your KYC details through KRA form with supporting documents at earliest to complete KYC-KRA requirement. If already submitted, kindly ignore. For any information, in this regard, please contact to our KYC Department on 022-66556772/73/74 or email at kyc@satco.co.in.
  • NSE - INZ 230012635 | 
  • BSE - INZ 010012839 | 
  • MCX - IN2000026431 / FMC : MCX/TCM/CORP/0598  | 
  • NCDEX - IN2000026431 / FMC : NCDEX/TM/CORP/1138 | 
  • CDSL – IN-DP-CDSL-727-2014  | 
  • PMS - INP000003492  | 
  • RESEARCH – INH000002343
  • © Copyright 2015. SATCO CAPITAL MARKETS LTD. || Designed Developed & Content Powered By Accord Fintech Pvt.Ltd.
VISIT COUNT     503396